BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 28670128)

  • 1. Clinical features of limbic encephalitis with LGI1 antibody.
    Wang M; Cao X; Liu Q; Ma W; Guo X; Liu X
    Neuropsychiatr Dis Treat; 2017; 13():1589-1596. PubMed ID: 28670128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three cases of antibody-LGI1 limbic encephalitis and review of literature.
    Bing-Lei W; Jia-Hua Z; Yan L; Zan Y; Xin B; Jian-Hua S; Hui-Juan W
    Int J Neurosci; 2019 Jul; 129(7):642-648. PubMed ID: 30112956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of nine cases of leucine-rich glioma inactivated 1 protein antibody-associated encephalitis.
    Li Y; Song F; Liu W; Wang Y
    Acta Neurol Belg; 2021 Aug; 121(4):889-897. PubMed ID: 32232701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures.
    Li Z; Cui T; Shi W; Wang Q
    Medicine (Baltimore); 2016 Jul; 95(28):e4244. PubMed ID: 27428233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study.
    Li W; Wu S; Meng Q; Zhang X; Guo Y; Cong L; Cong S; Zheng D
    BMC Neurol; 2018 Jul; 18(1):96. PubMed ID: 29980179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis.
    Irani SR; Michell AW; Lang B; Pettingill P; Waters P; Johnson MR; Schott JM; Armstrong RJ; S Zagami A; Bleasel A; Somerville ER; Smith SM; Vincent A
    Ann Neurol; 2011 May; 69(5):892-900. PubMed ID: 21416487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis.
    Chen C; Wang X; Zhang C; Cui T; Shi WX; Guan HZ; Ren HT; Shao XQ
    Epilepsy Behav; 2017 Dec; 77():90-95. PubMed ID: 29050866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural course of LGI1 encephalitis: 3-5 years of follow-up without immunotherapy.
    Szots M; Marton A; Kover F; Kiss T; Berki T; Nagy F; Illes Z
    J Neurol Sci; 2014 Aug; 343(1-2):198-202. PubMed ID: 24928080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and electrographic characteristics of seizures in LGI1-antibody encephalitis.
    Li LH; Ma CC; Zhang HF; Lian YJ
    Epilepsy Behav; 2018 Nov; 88():277-282. PubMed ID: 30332659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Electroencephalographic Features of the Seizures in Neuronal Surface Antibody-Associated Autoimmune Encephalitis.
    Wang Y; Yu Y; Hu Y; Li Y; Song F; Wang Y
    Front Neurol; 2020; 11():280. PubMed ID: 32431657
    [No Abstract]   [Full Text] [Related]  

  • 11. Pilomotor Seizures in a Patient With LGI1 Encephalitis.
    Yang J; Sun Q; Yang G
    Front Neurol; 2020; 11():61. PubMed ID: 32153488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Treatment and Follow-Up of Anti-LGI1 Limbic Encephalitis.
    Yu J; Yu X; Fang S; Zhang Y; Lin W
    Eur Neurol; 2016; 75(1-2):5-11. PubMed ID: 26694143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Anti-Leucine-Rich Glioma-Inactivated Protein 1 (Anti-LGI1) Limbic Encephalitis With New-Onset Panic Attacks.
    Coleman B; Sawhney K; LaPenna P
    Cureus; 2024 Apr; 16(4):e58406. PubMed ID: 38756253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.
    Irani SR; Stagg CJ; Schott JM; Rosenthal CR; Schneider SA; Pettingill P; Pettingill R; Waters P; Thomas A; Voets NL; Cardoso MJ; Cash DM; Manning EN; Lang B; Smith SJ; Vincent A; Johnson MR
    Brain; 2013 Oct; 136(Pt 10):3151-62. PubMed ID: 24014519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis of 9 cases with Anti-leucine-rich glioma inactivated 1 protein antibody associated limbic encephalitis].
    Zhang YX; Yang HL; Wu YY; Wang CC; Gao XY; Shi YY; Liu HQ; Huang Y; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2017 May; 97(17):1295-1298. PubMed ID: 28482428
    [No Abstract]   [Full Text] [Related]  

  • 16. LGI1 antibody-associated encephalitis without evidence of inflammation in CSF and brain MRI.
    Jia Y; Wang H; Zhang M; Wei M; Huang Z; Ye J; Liu A; Wang Y
    Acta Neurol Belg; 2023 Jun; 123(3):849-856. PubMed ID: 35527332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Voltage-Gated Potassium Channels (VGKC) Complex-Associated Disorders: Anti-LGI1 Encephalitis and Anti-Caspr2 Encephalitis].
    Watanabe O
    Brain Nerve; 2023 Jun; 75(6):721-727. PubMed ID: 37287355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faciobrachial motor seizures: A more apt description?
    Muthusamy S; Foroush NC; Seneviratne U
    Epilepsy Behav Rep; 2021; 16():100476. PubMed ID: 34505053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare case of anti-LGI1 limbic encephalitis with concomitant positive NMDAR antibodies.
    Ji T; Huang Z; Lian Y; Wang C; Zhang Q; Li J
    BMC Neurol; 2020 Sep; 20(1):336. PubMed ID: 32894089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric Manifestation of Anti-LGI1 Encephalitis.
    Endres D; Prüss H; Dressing A; Schneider J; Feige B; Schweizer T; Venhoff N; Nickel K; Meixensberger S; Matysik M; Maier SJ; Domschke K; Urbach H; Meyer PT; Tebartz van Elst L
    Brain Sci; 2020 Jun; 10(6):. PubMed ID: 32560097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.